JOHN SASSO — Lobbyist Profile | Poliscope

JOHN SASSO

Reported covered position: N/A

Filings

Clients

Firms

Years active

1999–2014

Associated filing income

$2,020,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
COVIDIEN INC	24	2009–2014
JOHN HANCOCK FINANCIAL SERVICES	6	2001–2003
STATE STREET BANK & TRUST	5	1999–2004

Lobbying firms

Firm	Filings	Years
ADVANCED STRATEGIES	35	1999–2014

Bills explicitly cited in this lobbyist’s assigned issues (28)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 523

Protect Medical Innovation Act of 2013

Client: COVIDIEN, INC. · Firm: ADVANCED STRATEGIES

Open original LDA filing ↗

Cited source text

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical innovation

S. 232

Medical Device Access and Innovation Protection Act

Client: COVIDIEN, INC. · Firm: ADVANCED STRATEGIES

Open original LDA filing ↗

Cited source text

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical innovation

Original LDA source filings (35)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

COVIDIEN, INC. via ADVANCED STRATEGIES

2014 · second_quarter · Q2

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

International Tax Issues

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2014 · first_quarter · Q1

Firm income: $70,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 31 more original filings

COVIDIEN, INC. via ADVANCED STRATEGIES

2013 · second_quarter · Q2

Firm income: $110,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Food and Drug Administration Processes

TAX

Taxation/Internal Revenue Code

S. 232 Medical Device Access & Innovation Protection Act H.R. 523 Protection of Medical innovation International Tax Issues

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2013 · first_quarter · Q1

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical Innovation

TAX

Taxation/Internal Revenue Code

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical innovation

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2012 · fourth_quarter · Q4

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

International Tax on direct foreign investment.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2012 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

International Tax on direct foreign investment

HCR

Health Issues

General Health Care Issues

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2012 · second_quarter · Q2

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S.3187, Food and Drug Administration Safety and innovation Act (Issues pertaining to 510k modification and the IDE standards)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2012 · first_quarter · Q1

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

General Issues Related to Health Care and the FDA Approval Process

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2011 · fourth_quarter · Q4

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

General Issues Relating to FDA Approval Process; International Tax on Direct Foreign Investment

TAX

Taxation/Internal Revenue Code

International Tax on Direct Foreign Investment

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2011 · third_quarter · Q3

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

International tax on Foreign Direct Investment

HCR

Health Issues

General Issues Related to FDA Approval Process

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2011 · second_quarter · Q2

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

General Issues Related to FDA Approval Process

TAX

Taxation/Internal Revenue Code

International tax on Foreign Direct Investment

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2011 · first_quarter · Q1

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

General Issues related to FDA device approval process; Issues related to Healthcare Reform (Accountable Care Organization Medical Device Tax)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2010 · fourth_quarter · Q4

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Issues Relating to International Tax

ENG

Energy/Nuclear

HR 3276 - American Medical Isotopes Production Act of 2009

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2010 · third_quarter · Q3

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

ENG

Energy/Nuclear

HR 3276 - American Medical Isotopes production Act of 2009

TAX

Taxation/Internal Revenue Code

Issues relating to international tax

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2010 · second_quarter · Q2

Firm income: $110,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Health Care Reform: HR 3590 Patient Protection and Affordable Care Act - issues relating to medical device tax

TAX

Taxation/Internal Revenue Code

HR 4213 - American Jobs and Closing Tax Loopholes Act of 2010

ENG

Energy/Nuclear

HR 3276 - American Medical Isotopes Production Act of 2009

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2010 · first_quarter · Q1

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

International tax on foreign direct investment

ENG

Energy/Nuclear

HR 3276 - American Medical isotopes Production Act of 2009 HEU/LEU related issues for nuclear medicine

HCR

Health Issues

HR 4872 - The Healthcare and education Affordability Reconciliation Act of 2010 HR 3590 - Patient Protection and Affordable Care Act of 2009 HR 3962 - Affordable Healthcare for Americans Act Issues related to the medical device tax/fee

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · fourth_quarter · Q4

Firm income: $120,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

International tax on foreign direct investment

FIN

Financial Institutions/Investments/Securities

Financial Regulatory Reform - Issues relating to derivatives Wall Street Reform and Consumer Protection Act (HR 4173)

ENG

Energy/Nuclear

HR 3276 American medical Isotopes Production Act of 2009 ENG Related issues for nuclear medicine

HCR

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · third_quarter · Q3

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

ENG

Energy/Nuclear

H.R. 3276 American Medical Isotopes Production Act

FIN

Financial Institutions/Investments/Securities

Financial Regulatory Reform

HCR

Health Issues

HR 3200, America's Affordable Health Choice Act of 2009 Senate Finance Committee Healthcare Reform Proposal S. 1679 Affordable Health Choices Act (HELP Bill)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · second_quarter · Q2

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

International Tax on Foreign Direct Investment

HCR

Health Issues

Health Care Reform, and S. 301, Physicians Payment Sunshine Act

ENG

Energy/Nuclear

American Medical Isotopes Production Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

International tax on foreign direct investment (S. 506,H.R. 1265)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Health Care, Taxation

ENV

Environment/Superfund

Health Care, Taxation

COVIDIEN, INC. via ADVANCED STRATEGIES

2009 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

Health Care, Taxation

HCR

Health Issues

Health Care, Taxation

STATE STREET BANK & TRUST via ADVANCED STRATEGIES

2004 · mid_year · MT

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2003 · year_end · YY

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

STATE STREET BANK & TRUST via ADVANCED STRATEGIES

2003 · mid_year · MM

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

STATE STREET BANK & TRUST via ADVANCED STRATEGIES

2002 · year_end · YY

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2002 · year_end · YY

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: SENATE

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2001 · year_end · YY

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2001 · mid_year · MM

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

STATE STREET BANK & TRUST via ADVANCED STRATEGIES

2001 · mid_year · MM

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2001 · year_end · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

JOHN HANCOCK FINANCIAL SERVICES via ADVANCED STRATEGIES

2001 · mid_year · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

STATE STREET BANK & TRUST via ADVANCED STRATEGIES

1999 · mid_year · MM

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Executive Office of the President (EOP), SENATE